Connection

Co-Authors

This is a "connection" page, showing publications co-authored by DAVID S FOLLOWILL and GEOFFREY IBBOTT.
Connection Strength

4.804
  1. Quality assurance for clinical trials. Front Oncol. 2013 Dec 19; 3:311.
    View in: PubMed
    Score: 0.468
  2. The Radiological Physics Center's standard dataset for small field size output factors. J Appl Clin Med Phys. 2012 08 08; 13(5):3962.
    View in: PubMed
    Score: 0.426
  3. MO-D-BRB-02: The Radiological Physics Center's Quality Audit Program: Where Can We Improve? Med Phys. 2012 Jun; 39(6Part21):3866.
    View in: PubMed
    Score: 0.421
  4. In regards to Dr. Eisbruch A et al. (Int J Radiat Oncol Biol Phys 2009. Electronic publication, June 17, 2009.). Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):639; author reply 639.
    View in: PubMed
    Score: 0.358
  5. Design, development, and implementation of the radiological physics center's pelvis and thorax anthropomorphic quality assurance phantoms. Med Phys. 2007 Jun; 34(6):2070-6.
    View in: PubMed
    Score: 0.297
  6. Independent evaluations of IMRT through the use of an anthropomorphic phantom. Technol Cancer Res Treat. 2006 Oct; 5(5):481-7.
    View in: PubMed
    Score: 0.284
  7. Comparison of electron beam characteristics from multiple accelerators. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):905-10.
    View in: PubMed
    Score: 0.243
  8. Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators. J Appl Clin Med Phys. 2003; 4(3):189-94.
    View in: PubMed
    Score: 0.219
  9. Development of a Monte Carlo multiple source model for inclusion in a dose calculation auditing tool. Med Phys. 2017 Sep; 44(9):4943-4951.
    View in: PubMed
    Score: 0.150
  10. Development of a flattening filter free multiple source model for use as an independent, Monte Carlo, dose calculation, quality assurance tool for clinical trials. Med Phys. 2017 Sep; 44(9):4952-4960.
    View in: PubMed
    Score: 0.150
  11. Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations. Med Phys. 2016 Aug; 43(8):4842.
    View in: PubMed
    Score: 0.140
  12. Robert J. Shalek, Ph.D., J.D. Med Phys. 2016 Jul; 43(7):4396.
    View in: PubMed
    Score: 0.140
  13. Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy. J Appl Clin Med Phys. 2014 Mar 06; 15(2):4523.
    View in: PubMed
    Score: 0.119
  14. Independent dose per monitor unit review of eight U.S.A. proton treatment facilities. Med Phys. 2014 Jan; 41(1):012103.
    View in: PubMed
    Score: 0.117
  15. Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials. J Appl Clin Med Phys. 2013 Jul 08; 14(4):4313.
    View in: PubMed
    Score: 0.114
  16. Credentialing results from IMRT irradiations of an anthropomorphic head and neck phantom. Med Phys. 2013 Feb; 40(2):022101.
    View in: PubMed
    Score: 0.110
  17. SU-E-T-95: Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom. Med Phys. 2012 Jun; 39(6Part11):3724.
    View in: PubMed
    Score: 0.105
  18. SU-E-T-190: Design, Development, and Evaluation of a Modified, Anthropomorphic, Head, Quality Assurance Phantom for Use in Stereotactic Radiosurgery. Med Phys. 2012 Jun; 39(6Part12):3746-3747.
    View in: PubMed
    Score: 0.105
  19. MO-D-BRB-04: The Approval Process for the Use of Proton Therapy in NCI-Sponsored Clinical Trials. Med Phys. 2012 Jun; 39(6Part21):3866.
    View in: PubMed
    Score: 0.105
  20. MO-D-BRB-03: Comparison of Proton Therapy Institutional Data Collected by the RPC. Med Phys. 2012 Jun; 39(6Part21):3866.
    View in: PubMed
    Score: 0.105
  21. Angular dependence of the nanoDot OSL dosimeter. Med Phys. 2011 Jul; 38(7):3955-62.
    View in: PubMed
    Score: 0.099
  22. Technical note: Heterogeneity dose calculation accuracy in IMRT: study of five commercial treatment planning systems using an anthropomorphic thorax phantom. Med Phys. 2008 Dec; 35(12):5434-9.
    View in: PubMed
    Score: 0.083
  23. Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int J Radiat Oncol Biol Phys. 2008; 71(1 Suppl):S71-5.
    View in: PubMed
    Score: 0.077
  24. Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom. Med Phys. 2007 May; 34(5):1850-7.
    View in: PubMed
    Score: 0.074
  25. Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 2005 Oct 01; 63(2):577-83.
    View in: PubMed
    Score: 0.066
  26. A reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial eye plaque dosimetry. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):889-98.
    View in: PubMed
    Score: 0.057
  27. Differences in electron beam dosimetry using two commercial ionization chambers and the TG-21 protocol: another reason to switch to TG-51. J Appl Clin Med Phys. 2003; 4(2):124-31.
    View in: PubMed
    Score: 0.055
  28. Model for Estimating Power and Downtime Effects on Teletherapy Units in Low-Resource Settings. J Glob Oncol. 2017 Oct; 3(5):563-571.
    View in: PubMed
    Score: 0.036
  29. Addendum to the AAPM's TG-51 Protocol for Clinical Reference Dosimetry of High-Energy Photon Beams. Igaku Butsuri. 2017; 37(1):2-24.
    View in: PubMed
    Score: 0.036
  30. Addendum to the AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon beams. Med Phys. 2014 Apr; 41(4):041501.
    View in: PubMed
    Score: 0.030
  31. Predictability of electron cone ratios with respect to linac make and model. J Appl Clin Med Phys. 2003; 4(2):172-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.